MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,406,921 | -25.1% | 43,871 | +18.5% | 0.00% | -20.0% |
| Q2 2023 | $8,554,161 | -40.3% | 37,031 | -37.4% | 0.01% | -37.5% |
| Q1 2023 | $14,336,948 | -20.2% | 59,180 | -4.3% | 0.01% | -20.0% |
| Q4 2022 | $17,956,897 | +437.0% | 61,867 | +20.2% | 0.01% | +400.0% |
| Q3 2022 | $3,344,000 | -5.4% | 51,450 | +4.2% | 0.00% | 0.0% |
| Q2 2022 | $3,534,000 | -27.5% | 49,372 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $4,875,000 | +62.5% | 49,678 | +40.3% | 0.00% | +100.0% |
| Q4 2021 | $3,000,000 | +80.3% | 35,399 | +69.8% | 0.00% | 0.0% |
| Q3 2021 | $1,664,000 | -15.1% | 20,845 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $1,961,000 | -86.5% | 20,127 | -83.8% | 0.00% | -87.5% |
| Q1 2021 | $14,525,000 | +565.7% | 124,176 | +532.7% | 0.01% | +700.0% |
| Q4 2020 | $2,182,000 | +5.1% | 19,626 | +12.3% | 0.00% | 0.0% |
| Q3 2020 | $2,076,000 | +5.5% | 17,482 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $1,968,000 | -60.9% | 17,377 | -77.0% | 0.00% | -75.0% |
| Q1 2020 | $5,039,000 | -31.2% | 75,474 | -6.2% | 0.00% | -20.0% |
| Q4 2019 | $7,329,000 | +497.3% | 80,466 | +464.0% | 0.01% | +400.0% |
| Q3 2019 | $1,227,000 | -16.4% | 14,268 | +1.8% | 0.00% | 0.0% |
| Q2 2019 | $1,468,000 | -28.8% | 14,020 | -14.9% | 0.00% | 0.0% |
| Q1 2019 | $2,063,000 | -21.9% | 16,480 | -29.8% | 0.00% | -50.0% |
| Q4 2018 | $2,643,000 | -88.6% | 23,464 | -78.3% | 0.00% | -71.4% |
| Q3 2018 | $23,179,000 | +13.9% | 108,252 | +48.8% | 0.01% | +16.7% |
| Q2 2018 | $20,346,000 | +236.4% | 72,753 | +40.4% | 0.01% | +100.0% |
| Q1 2018 | $6,048,000 | +384.2% | 51,806 | +280.2% | 0.00% | +200.0% |
| Q4 2017 | $1,249,000 | -34.4% | 13,625 | -67.9% | 0.00% | 0.0% |
| Q3 2017 | $1,905,000 | +765.9% | 42,381 | +211.0% | 0.00% | – |
| Q2 2017 | $220,000 | – | 13,627 | +1362600.0% | 0.00% | – |
| Q1 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |